YD
Daali, Youssef
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | BJCP. British journal of clinical pharmacology | 2025 | 37 | 0 | |||
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics | 2025 | 60 | 77 | |||
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology & therapeutics | 2025 | 68 | 248 | |||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology | 2025 | 70 | 0 | |||
| Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients | Therapeutic drug monitoring | 2024 | 11 | 43 | |||
| Application of Microwave-Assisted Method for Lutein Extraction from Pistachio Waste | Journal of nuts | 2024 | 113 | 339 | |||
| Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modeling | Pharmaceuticals | 2024 | 99 | 172 | |||
| Optimization of Lutein Extraction from Pistachio Waste Using Experimental Design and Ultrasonic Method | Waste and biomass valorization | 2024 | 111 | 0 | |||
| Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping | Journal of chromatography. B | 2024 | 103 | 115 | |||
| In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting | Pharmacology research & perspectives | 2024 | 96 | 99 | |||
| Practice of CYP450 genotyping and phenotyping in children in a real-life setting | Frontiers in pharmacology | 2023 | 77 | 188 | |||
| Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs | Pharmaceutics | 2023 | 114 | 339 | |||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | 2023 | 142 | 348 | |||
| Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail | Basic & clinical pharmacology & toxicology | 2023 | 118 | 0 | |||
| Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals | 2023 | 67 | 48 | |||
| Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT | Transplantation and cellular therapy | 2023 | 89 | 114 | |||
| Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approach | Journal of personalized medicine | 2023 | 95 | 31 | |||
| Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol | Frontiers in pain research | 2023 | 126 | 214 | |||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | 2023 | 132 | 306 | |||
| Joint Analysis of Phenotypic and Genomic Diversity Sheds Light on the Evolution of Xenobiotic Metabolism in Humans | Genome biology and evolution | 2022 | 536 | 219 | |||
| Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs | Frontiers in pharmacology | 2022 | 187 | 150 | |||
| Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response | Pharmaceuticals | 2022 | 83 | 29 | |||
| Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots | Clinical and translational science | 2022 | 242 | 222 | |||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | 2022 | 153 | 128 | |||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | 2022 | 224 | 302 | |||
| Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity | Frontiers in psychiatry | 2022 | 105 | 125 | |||
| Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients | Frontiers in aging neuroscience | 2022 | 89 | 156 | |||
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | 2022 | 163 | 247 | |||
| Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics | CPT: pharmacometrics & systems pharmacology | 2022 | 274 | 475 | |||
| Variations in the Frequencies of Polymorphisms in the CYP450s Genes in Eight Major Ethnicities of Iran: A Review of the Human Data | Journal of personalized medicine | 2022 | 67 | 285 | |||
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology & therapeutics | 2022 | 178 | 369 | |||
| Personalized Medicine : Pharmacokinetics | Journal of personalized medicine | 2022 | 73 | 58 | |||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | 2021 | 210 | 184 | |||
| Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice | ACS Nano | 2021 | 393 | 509 | |||
| Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy | Annual Review of Pharmacology and Toxicology | 2021 | 453 | 1 | |||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | 2021 | 175 | 0 | |||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | 2021 | 286 | 5 | |||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | 2021 | 280 | 305 | |||
| The 1β-Hydroxy-Deoxycholic Acid to Deoxycholic Acid Urinary Metabolic Ratio: Toward a Phenotyping of CYP3A Using an Endogenous Marker? | Journal of personalized medicine | 2021 | 225 | 65 | |||
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | 2021 | 327 | 197 | |||
| The tyrosine kinase inhibitor nilotinib inhibits SARS‐CoV‐2 in vitro | Basic & Clinical Pharmacology & Toxicology | 2021 | 233 | 2 | |||
| Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS/MS | Journal of chromatography. B | 2021 | 434 | 506 | |||
| Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data | Journal of personalized medicine | 2021 | 173 | 86 | |||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | 2021 | 183 | 272 | |||
| Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study | CPT: pharmacometrics & systems pharmacology | 2021 | 245 | 185 | |||
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | 2020 | 439 | 184 | |||
| Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis | British Journal of Clinical Pharmacology | 2020 | 230 | 208 | |||
| Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins | Drug Safety | 2020 | 722 | 375 | |||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | 2020 | 334 | 550 | |||
| GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers | European Journal of Pain | 2020 | 257 | 1 | |||
| Bioavailability of Vortioxetine After a Roux-en-Y Gastric Bypass | Obesity Surgery | 2020 | 265 | 1 | |||
| Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine-3-glucuronide and morphine-6-glucuronide in human astrocytes | Journal of Neuroscience Research | 2020 | 315 | 2 | |||
| Modern approaches for the phenotyping of cytochrome P450 enzymes in children | Expert Review of Clinical Pharmacology | 2020 | 214 | 1 | |||
| Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children | Therapeutic Drug Monitoring | 2020 | 451 | 194 | |||
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | 2020 | 290 | 1 | |||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | 2020 | 357 | 105 | |||
| Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail | Journal of Personalized Medicine | 2019 | 476 | 308 | |||
| Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches | Clinical Pharmacokinetics | 2019 | 425 | 3 | |||
| Variables of interest to predict glomerular filtration rate in preterm newborns in the first days of life | Pediatric Nephrology | 2019 | 390 | 1 | |||
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | 2019 | 500 | 2 | |||
| Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma | Biochemical and Biophysical Research Communications | 2019 | 382 | 260 | |||
| Liquid Chromatography-Tandem Mass Spectrometry Method for Ticagrelor and its Active Metabolite Determination in Human Plasma: Application to a Pharmacokinetic Study | Current Analytical Chemistry | 2019 | 471 | 1 | |||
| CYP450 activities before and after Roux-en-Y gastric bypass: correlation with their intestinal and liver content | Surgery for Obesity and Related Diseases | 2019 | 364 | 0 | |||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | 2019 | 469 | 4 | |||
| Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment | Integrative Cancer Therapies | 2019 | 385 | 128 | |||
| Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactions | CPT: pharmacometrics & systems pharmacology | 2019 | 411 | 447 | |||
| Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled study | European Journal of Pain | 2019 | 400 | 2 | |||
| Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling | Pediatric Research | 2019 | 335 | 2 | |||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | 2018 | 736 | 830 | |||
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | 2018 | 522 | 880 | |||
| Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting | Journal of Clinical Psychiatry | 2018 | 490 | 0 | |||
| Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software | Biopharmaceutics & Drug Disposition | 2018 | 625 | 12 | |||
| Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes | Basic & Clinical Pharmacology & Toxicology | 2018 | 513 | 845 | |||
| Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance | Therapeutic Drug Monitoring | 2018 | 861 | 746 | |||
| Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report | European Journal of Anaesthesiology | 2018 | 445 | 365 | |||
| Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) | BMC Pharmacology & Toxicology | 2017 | 518 | 219 | |||
| Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactions | Clinical Pharmacology and Therapeutics | 2017 | 496 | 5 | |||
| Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases | Journal of pharmaceutical and biomedical analysis | 2017 | 662 | 839 | |||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | 2017 | 661 | 187 | |||
| Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future | Clinical Pharmacology and Therapeutics | 2017 | 598 | 0 | |||
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | 2017 | 620 | 273 | |||
| Hepatocyte Concentrations of Indocyanin Green (ICG) Reflects Transfer Rates Across Membrane Transporters | Basic & clinical pharmacology & toxicology | 2017 | 544 | 3 | |||
| Plasma concentrations of transdermal fentanyl and buprenorphine in pigs (Sus scrofa domesticus) | Veterinary Anaesthesia and Analgesia | 2017 | 479 | 1 | |||
| Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine | Journal of Pharmaceutical Sciences | 2017 | 490 | 0 | |||
| Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis | Free radical biology & medicine | 2016 | 671 | 289 | |||
| An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure | Toxicology and applied pharmacology | 2016 | 642 | 2 | |||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | 2016 | 508 | 241 | |||
| The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | Neuropharmacology | 2016 | 591 | 320 | |||
| Detection of busulfan adducts on proteins | RCM. Rapid communications in mass spectrometry | 2016 | 669 | 263 | |||
| Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | 2016 | 713 | 1 | |||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | 2016 | 666 | 971 | |||
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | 2016 | 624 | 0 | |||
| Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells | Fundamental & clinical pharmacology | 2016 | 629 | 21 | |||
| Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study | Clinical therapeutics | 2016 | 556 | 2 | |||
| Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method | Basic & clinical pharmacology & toxicology | 2016 | 679 | 802 | |||
| Markers of Individual Drug Metabolism: Towards the Development of a Personalized Antidepressant Prescription | Current drug metabolism | 2015 | 587 | 3 | |||
| Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | 2015 | 644 | 6 | |||
| Augmented renal clearance, low ß-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study | International journal of antimicrobial agents | 2015 | 834 | 3 | |||
| GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic-pharmacodynamic study comparing clobazam with clonazepam in healthy volunteers | Pain | 2015 | 626 | 3 | |||
| Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review | Current drug metabolism | 2014 | 656 | 0 | |||
| Incorporation of Flurbiprofen in a 4-Drug Cytochrome P450 Phenotyping Cocktail | Basic & clinical pharmacology & toxicology | 2014 | 647 | 4 | |||
| Phenotyping of CYP450 in human liver microsomes using the cocktail approach | Analytical & bioanalytical chemistry | 2014 | 537 | 2 | |||
| Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | 2014 | 650 | 2 | |||
| Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots | Clinical pharmacology and therapeutics | 2014 | 925 | 498 | |||
| Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity | AIDS research and therapy | 2014 | 737 | 964 | |||
| The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation | Pharmacogenomics journal | 2014 | 735 | 8 | |||
| Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model | CPT: pharmacometrics & systems pharmacology | 2014 | 678 | 295 | |||
| Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma | Bioanalysis | 2014 | 767 | 5 | |||
| Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | 2014 | 673 | 0 | |||
| A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies | Journal of pharmaceutical and biomedical analysis | 2014 | 576 | 7 | |||
| Antihyperalgesic Effect of the GABA(A) Ligand Clobazam in a Neuropathic Pain Model in Mice: A Pharmacokinetic-Pharmacodynamic Study | Basic & clinical pharmacology & toxicology | 2013 | 644 | 431 | |||
| Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Arteriosclerosis, thrombosis, and vascular biology | 2013 | 667 | 0 | |||
| Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model | Basic & clinical pharmacology & toxicology | 2013 | 600 | 3 | |||
| Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model | The journal of antimicrobial chemotherapy | 2013 | 587 | 0 | |||
| Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers | Basic & clinical pharmacology & toxicology | 2013 | 662 | 434 | |||
| Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial | Pain physician | 2013 | 626 | 1,137 | |||
| Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain | Pain physician | 2013 | 793 | 744 | |||
| Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | 2013 | 771 | 966 | |||
| Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs | Drug metabolism and disposition | 2013 | 811 | 688 | |||
| NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion | Diabetes | 2012 | 818 | 550 | |||
| Transcriptional regulation of CYP2C19 and its role in altered enzyme activity | Current drug metabolism | 2012 | 608 | 0 | |||
| Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient | AIDS | 2012 | 636 | 628 | |||
| Validation of the simplified UVB model to assess the pharmacodynamics of analgesics in healthy human volunteers | Chimia | 2012 | 805 | 1,168 | |||
| Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview | Basic & clinical pharmacology & toxicology | 2012 | 653 | 745 | |||
| Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | 2012 | 621 | 0 | |||
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | 2012 | 591 | 0 | |||
| Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot | Clinical pharmacology and therapeutics | 2012 | 650 | 0 | |||
| Analgesics in patients with hepatic impairment: pharmacology and clinical implications | Drugs | 2012 | 704 | 3 | |||
| Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection | Journal of viral hepatitis | 2012 | 663 | 0 | |||
| A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry | RCM. Rapid communications in mass spectrometry | 2012 | 846 | 901 | |||
| A randomized, controlled trial validates a peripheral supra-additive antihyperalgesic effect of a paracetamol-ketorolac combination | Basic & clinical pharmacology & toxicology | 2011 | 678 | 0 | |||
| Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients | Metabolism, clinical and experimental | 2011 | 691 | 0 | |||
| HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Neuropharmacology | 2011 | 816 | 688 | |||
| How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver | The Journal of pharmacology and experimental therapeutics | 2011 | 634 | 0 | |||
| Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Journal of pharmaceutical and biomedical analysis | 2011 | 744 | 902 | |||
| Two structurally different T-type Ca2+ channel inhibitors, mibefradil and pimozide, protect CA1 neurons from delayed death after global ischemia in rats | Fundamental & clinical pharmacology | 2011 | 18 | 0 | |||
| The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone | British journal of pharmacology | 2010 | 877 | 2 | |||
| Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 674 | 0 | |||
| Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety | British journal of pharmacology | 2010 | 652 | 1 | |||
| Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoprotein | Basic & clinical pharmacology & toxicology | 2009 | 641 | 2 | |||
| Two-dimensional liquid chromatography-ion trap mass spectrometry for the simultaneous determination of ketorolac enantiomers and paracetamol in human plasma: application to a pharmacokinetic study | Journal of chromatography | 2009 | 562 | 0 | |||
| The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction | Pharmacogenomics journal | 2009 | 915 | 0 | |||
| P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone | Fundamental & clinical pharmacology | 2009 | 676 | 0 | |||
| Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers | Drug metabolism letters | 2008 | 861 | 0 | |||
| Lack of interaction of the NMDA receptor antagonists dextromethorphan and dextrorphan with P-glycoprotein | Current drug metabolism | 2008 | 655 | 4 | |||
| Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity in fibromyalgia patients | Journal of chromatography. B | 2008 | 626 | 4 | |||
| Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study | Clinical therapeutics | 2007 | 770 | 0 | |||
| Development and validation of a new reversed-phase ion pairing liquid chromatographic method with fluorescence detection for penciclovir analysis in plasma and aqueous humor | Journal of chromatography. B | 2005 | 612 | 2 | |||
| Codeine intoxication associated with ultrarapid CYP2D6 metabolism | The New England journal of medicine | 2004 | 560 | 1 | |||
| High performance liquid chromatography of acarbose and its metabolite on porous graphitic carbon column | Journal of separation science | 2002 | 945 | 1 | |||
| Simultaneous analysis of polyhydroxylated alkaloids by capillary electrophoresis using borate complexation and evaluation of sweeping technique for sensitivity improvement | Chromatographia | 2002 | 651 | 1 | |||
| Calystegine distribution in some solanaceous species | Phytochemistry | 2001 | 645 | 0 | |||
| Capillary electrophoresis and high-performance anion exchange chromatography for monitoring caseinoglycomacropeptide sialylation | Journal of pharmaceutical and biomedical analysis | 2001 | 566 | 0 | |||
| Routine o-glycan characterization in nutritional supplements--a comparison of analytical methods for the monitoring of the bovine kappa-casein macropeptide glycosylation | Journal of chromatography | 2001 | 626 | 0 | |||
| Use of borate complexation for the separation of non-UV-absorbing calystegines by capillary electrophoresis | Journal of chromatography | 2000 | 650 | 0 | |||
| Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detection | Chemical and pharmaceutical bulletin | 2000 | 569 | 0 | |||
| Experimental design for enantioselective separation of celiprolol by capillary electrophoresis using sulfated beta-cyclodextrin | Electrophoresis | 1999 | 630 | 2 | |||
| Development and validation of liquid chromatography and capillary electrophoresis methods for acarbose determination in pharmaceutical tablets | Journal of pharmaceutical and biomedical analysis | 1998 | 632 | 0 |
